Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bosentan
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
2Bosentan 125 MG
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51 💬
3Bosentan 62.5 MG
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51 💬
4Bosentan administration
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
5Bosentan dispersible tablets
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
6Bosentan group
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51 💬
7Bosentan monohydrat
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
8Bosentan monohydrate
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 51, 84, 86, 88 💬
9Bosentan mylan
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 41 💬
10Bosentan, ambrisentan
(D07538)
[1] Bosentan[2] Bosentan ,
Bosentan (D07538) 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
11DUO-therapy with sildenafil + bosentan
(D07538)
----[1] 86 💬
12Sildenafil 20MG and bosentan 62.5MG
(D07538)
[1] Sildenafil[2] Sildenafil citrate ,
Sildenafil 💬
[1] PDE5 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
13Sildenafil singly or IN association with bosentan
(D07538)
[1] Sildenafil[2] Sildenafil citrate ,
Sildenafil 💬
[1] PDE5 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬